Medine.co.uk

Telmisartan 80 Mg Tablets

Document: leaflet MAH GENERIC_PL 04416-1115 change

PACKAGE LEAFLET: INFORMATION FOR THE USER


SZ00000LT000


Telmisartan 20 mg Tablets Telmisartan 40 mg Tablets Telmisartan 80 mg Tablets


Telmisartan


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

   Keep this leaflet. You may need to read it again.

•    If you have any further questions, ask your doctor or pharmacist.

•    This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

•    If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.


What is in this leaflet:

1.    What Telmisartan is and what it is used for

2.    What you need to know before you take Telmisartan

3.    How to take Telmisartan

4.    Possible side effects

5.    How to store Telmisartan

6.    Contents of the pack and other information


What Telmisartan is and what it is used for


Telmisartan belongs to a group of medicines known as angiotensin II receptor antagonists. Angiotensin II is a substance produced in your body which causes your blood vessels to narrow, thus increasing your blood pressure. Telmisartan blocks the effect of angiotensin II so that the blood vessels relax, and your blood pressure is lowered.

Telmisartan is used to treat essential hypertension (high blood pressure). ‘Essential’ means that the high blood pressure is not caused by any other condition.

High blood pressure, if not treated, can damage blood vessels in several organs, which could sometimes lead to heart attack, heart or kidney failure, stroke, or blindness. There are usually no symptoms of high blood pressure before damage occurs. Therefore it is important to measure blood pressure regularly to check if it is within the normal range.


to the medicines listed below taken at the same time with Telmisartan:

•    lithium-containing medicines to treat some types of depression

•    medicines that may increase blood potassium levels such as salt substitutes containing potassium, potassium-sparing diuretics (certain 'water tablets'), ACE inhibitors, angiotensin II receptor antagonists, NSAIDs (non steroidal anti-inflammatory medicines, e.g. aspirin or ibuprofen), heparin, immunosuppressives (e.g. cyclosporin or tacrolimus), and the antibiotic trimethoprim

•    diuretics ('water tablets'), especially if taken in high doses together with this medicine, may lead to excessive loss of body water and low blood pressure (hypotension).

•    aliskiren, a medicine used to treat high blood pressure

•    digoxin

The effect of this medicine may be reduced if you also take NSAIDs (e.g. aspirin or ibuprofen) or corticosteroids.


Telmisartan is also used to reduce cardiovascular events (i.e. heart attack or stroke) in patients who are at risk because they have a reduced or blocked blood supply to the heart or legs, or have had a stroke or have high risk diabetes. Your doctor can tell you if you are at high risk for such events.


What you need to know before you take Telmisartan


Do NOT take Telmisartan if you:

•    are allergic to telmisartan or any of the other ingredients of this medicine (listed in section 6 and the end of section 2).

•    are more than 3 months pregnant. (It is also better to avoid Telmisartan in early pregnancy - see pregnancy section.)

•    have severe liver problems such as cholestasis or biliary obstruction (problems with the drainage of bile from the liver and gall bladder) or any other severe liver disease.

•    if you have diabetes mellitus or impaired kidney function and you are treated with aliskiren

If any of the above situations applies to you, tell your doctor or pharmacist before taking Telmisartan

Warnings and precautions

Tell your doctor if you are suffering or have ever suffered from any of the following conditions or illnesses:

•    kidney disease or kidney transplant

•    renal artery stenosis (narrowing of the blood vessels to one or both kidneys)

•    liver disease

•    heart problems

•    raised aldosterone levels (water and salt retention in the body along with imbalance of various blood minerals)

•    low blood pressure (hypotension),likely to occur if you are dehydrated (excessive loss of body water) or have salt deficiency due to diuretic therapy ('water tablets'), a low-salt diet, diarrhoea or vomiting

•    elevated potassium levels in your blood

•    diabetes.

Talk to your doctor before taking Telmisartan:

•    if you are taking aliskiren, a medicine used to treat high blood pressure

•    if you are taking digoxin.

You must tell your doctor if you think you are (or might become) pregnant. Telmisartan is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).

In case of surgery or anaesthesia, tell your doctor that you are taking Telmisartan.

Telmisartan may be less effective in lowering blood pressure in black patients.

Children and adolescents

The use of Telmisartan in children and adolescents up to the age of 18 years is not recommended.

Other medicines and Telmisartan

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Your doctor may need to change the dose of these medicines or take other precautions. In some cases you may have to stop taking one of the medicines. This applies especially


Telmisartan may increase the blood pressure lowering effect of other medicines used to treat high blood pressure or of medicines with blood pressure lowering potential (e.g. baclofen, amifostine). Furthermore, low blood pressure may be aggravated by alcohol, barbiturates, narcotics or antidepressants. You may notice this as dizziness when standing up. You should consult with your doctor if you need to adjust the dose of your other medicine while taking Telmisartan.

Taking Telmisartan with food and drink

You can take Telmisartan with or without food.

Pregnancy and breast-feeding

Pregnancy

You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking Telmisartan before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Telmisartan. Telmisartan is not recommended in early pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.

Breast-feeding

Tell your doctor if you are breast-feeding or about to start breast-feeding. Telmisartan is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed, especially if your baby is newborn, or was born prematurely.

Driving and using machines

Some people feel dizzy or tired when taking Telmisartan. If you feel dizzy or tired, do not drive or operate machinery.

Telmisartan contains lactose.

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.


3 How to take Telmisartan


Always take Telmisartan exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose of Telmisartan is one tablet a day.

•    Try to take the tablet at the same time each day.

•    You can take Telmisartan with or without food.

•    The tablets should be swallowed with some water or other non-alcoholic drink.

•    It is important that you take Telmisartan every day until your doctor tells you otherwise.

•    If you have the impression that the effect of Telmisartan is too strong or too weak, talk to your doctor or pharmacist.

•    Tablets with a score line can be divided into equal halves

For treatment of high blood pressure, the usual dose of Telmisartan for most patients is one 40 mg tablet once a day to control blood pressure over the 24-hour period. However, sometimes your doctor may recommend a lower dose of 20 mg or a higher dose of 80 mg.

Continued on the next page >>


O

-3-


A

Artwork Proof Box

Ref: V009: CDS update for SPC & PIL+ National phase

Proof no.

Date prepared:

Font size:

006.2

27/01/2014

10pt

Colours:

| Black

Fonts:

Helvetica

Dimensions: 165

x620 mm

__


O

"3

-3-


Telmisartan may also be used in combination with diuretics ('water tablets') such as hydrochlorothiazide which has been shown to have an additive blood pressure lowering effect with Telmisartan.

For reduction of cardiovascular events, the usual dose of Telmisartan is one 80 mg tablet once a day. At the beginning of the preventive therapy with Telmisartan 80 mg, blood pressure should be frequently monitored.

Use in children

The use of Telmisartan in children and adolescents up to the age of 18 years is not recommended.

Use in the elderly

No dosing adjustment is necessary for elderly patients.

Use in impaired liver function

If your liver is not working properly, the usual dose should not be more than 40 mg once daily.

Use in impaired kidney function

No dosage adjustment is necessary in patients with impaired kidney function.

If you have severe kidney function impairment or if you are undergoing haemodialysis your doctor may prescribe a lower starting dose of 20 mg.

If you take more Telmisartan than you should

If you accidentally take too many tablets, contact your doctor, pharmacist, or your nearest hospital emergency department immediately.

If you forget to take Telmisartan

If you forget to take a dose, do not worry. Take it as soon as you remember then carry on as before. If you do not take your tablet on one day, take your normal dose on the next day. Do not take a double dose to make up for forgotten individual doses.

If you stop taking Telmisartan

Always consult your doctor if you wish to stop taking this medicine. Even if you feel well, it may be necessary to continue taking this medicine.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist


are more likely to experience this side effect)

•    rapid swelling of the skin and mucosa which can also lead to death (angioedema also with fatal outcome)

•    eczema (a skin disorder)

•    redness of skin

•    hives (urticaria)

•    severe drug rash

•    joint pain (arthralgia)

•    pain in extremity

•    tendon pain

•    flu-like-illness

•    decreased haemoglobin (a blood protein)

•    increased levels of uric acid, increased hepatic enzymes or creatine phosphokinase in the blood

Very rare side effects (may affect up to 1 in

10,000 people):

•    progressive scarring of lung tissue (interstitial lung disease)**.

•    The event may have happened by chance or could be related to a mechanism currently not known.

**Cases of progressive scarring of lung tissue have been reported during intake of telmisartan. However, it is not known whether telmisartan was the cause.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

You can also report side effects directly via the Yellow Card Scheme: www.mhra.gov.uk/yellowcard. By reporting side affects you can help provide more information on the safety of this medicine.


5 How to store Telmisartan


4 Possible side effects


Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.

Store in the original package in order to protect from moisture.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


Like all medicines, this medicine can cause side effects, although not everybody gets them.

Some side effects can be serious and need immediate medical attention:

You should see your doctor immediately if you experience any of the following symptoms: Sepsis* (often called "blood poisoning", is a severe infection with whole-body inflammatory response), rapid swelling of the skin and mucosa (angioedema); these side effects are rare (may affect up to 1 in 1,000 people) but are extremely serious and patients should stop taking the medicine and see their doctor immediately. If these effects are not treated they could be fatal.

Possible side effects:

Common side effects (may affect up to 1 in

10 people:

   low blood pressure (hypotension) in users treated for reduction of cardiovascular events

Uncommon side effects (may affect up to 1 to 100 people):

•    urinary tract infections

•    upper respiratory tract infection (e.g. sore throat, inflamed sinuses, common cold)

•    deficiency in red blood cells (anaemia)

•    high potassium levels

•    difficulty falling asleep (insomnia)

•    feeling sad (depression)

•    fainting (syncope)

•    feeling of spinning (vertigo)

•    slow heart rate (bradycardia)

•    low blood pressure (hypotension) in users treated for high blood pressure

•    dizziness on standing up (orthostatic hypotension)

•    shortness of breath

•    cough

•    abdominal pain

•    diarrhoea

•    discomfort in the abdomen

•    bloating

•    vomiting

•    itching

•    increased sweating

•    drug rash

•    back pain

•    muscle cramps

•    muscle pain (myalgia)

•    kidney impairment including acute kidney failure

•    pain in the chest

•    feeling of weakness

•    increased level of creatinine in the blood.

Rare side effects (may affect up to 1 in

1,000 people):

•    sepsis* (often called “blood poisoning”, is a severe infection with whole-body inflammatory response which can lead to death)

•    increase in certain white blood cells (eosinophilia)

•    low platelet count (thrombocytopenia)

•    severe allergic reaction (anaphylactic reaction)

•    allergic reaction (e.g. rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure).

•    low blood sugar levels (in diabetic patients)

•    feeling anxious

•    somnolence

•    impaired vision

•    fast heart beat (tachycardia)

•    dry mouth

•    upset stomach

•    abnormal liver function (Japanese patients


Contents of the pack and other information


What Telmisartan contains

Telmisartan 20 mg, tablets

The active substance is telmisartan. Each

tablet contains 20 mg of telmisartan.

Telmisartan 40 mg, tablets

The active substance is telmisartan. Each

tablet contains 40 mg of telmisartan.

Telmisartan 80 mg, tablets

The active substance is telmisartan. Each

tablet contains 80 mg of telmisartan.

The other ingredients are:

Sodium Hydroxide Meglumine Povidone K25 Lactose monohydrate Povidone Crospovidone Lactose anhydrous Magnesium Stearate

- for further information on lactose see end of Section 2

What Telmisartan looks like and contents of the pack

Telmisartan 20 mg, tablets

White, round, plain tablet, debossed with ‘20’

on one side.

Telmisartan 40 mg, tablets White, oblong, plain tablet, scored on one side and debossed with ‘40’ on the other side.

Telmisartan 80 mg, tablets White, oblong, plain tablet, scored on one side and debossed with ‘80’ on the other side.

20mg

Al//Al blisters containing 7, 10, 14, 20, 21,

28, 30, 50, 56, 60, 84, 90, 98, 100 tablets.

40 mg, 80 mg

Al//Al blisters containing 7, 10, 14, 20, 21,

28, 30, 50, 56, 60, 84, 90, 98, 100 tablets.

Al//Al unit dose blisters containing 28 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Sandoz Ltd, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR United Kingdom

Manufacturer

Lek pharmaceuticals d.d. Ljubljana, Slovenia Lek pharmaceuticals d.d. Lendava, Slovenia Lek S.A. Warszawa, Poland Salutas Pharma GmbH, Barleben, Germany Salutas Pharma GmbH, Gerlingen, Germany S.C. Sandoz, S.R.L., Str. Livezeni nr 7A, 540472, Targu Mures, Romania Lek S.A, ul. Podlipie 16, 95-010 Strykow, Poland

This leaflet was last revised 01/2014.


SZ00000LT000

00000000


A

Artwork Proof Box

Ref: V009: CDS update for SPC & PIL+ National phase

Proof no.

Date prepared:

Font size:

006.2

27/01/2014

10pt

Colours:

| Black

Fonts:

Helvetica

Dimensions: 165

x620 mm

__